The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients.
about
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomesSustained proliferation in cancer: Mechanisms and novel therapeutic targetsAnticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDACNuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression.SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinomaImmunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma.Transcription factors zeb1, twist and snai1 in breast carcinoma.Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsSnail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer.MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation.The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival.Snail1 expression in colorectal cancer and its correlation with clinical and pathological parametersIntegrin regulation of beta-catenin signaling in ovarian carcinoma.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR ActivityExpression and clinical significance of hypoxia-inducible factor 1α, Snail and E-cadherin in human ovarian cancer cell lines.Epithelial-mesenchymal transition in ovarian carcinomaInvasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancerSnail promotes an invasive phenotype in lung carcinomaPrognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancerAnticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosisElevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen speciesSnail1 protein in the stroma as a new putative prognosis marker for colon tumours.Nuclear expression of snail is an independent negative prognostic factor in human breast cancer.A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cellsExpression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinomaGambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways.Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations.Exploiting p70 S6 kinase as a target for ovarian cancer.EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
P2860
Q24604279-D31D53AE-F915-4BC7-824F-0FE74D196117Q28396388-06A9BD52-FDC8-42A7-A28F-6634D7CF662BQ28477173-91D0F5E3-1B26-499E-924C-0D801A95C249Q33495389-7926D9C7-4165-4CB1-A7E9-F317948A1DC7Q33533958-8DC67FC4-94E9-4B9D-A0B4-BF15A20CCA60Q33686502-34DF1486-E22F-44A7-8B27-CDB3A4200336Q33821467-6E071EB3-5509-4CF7-AC69-FC6770F106E8Q33829859-30504AA3-984F-45E1-ABA4-FD875CF2C63FQ33977108-F40DFF47-EBDC-4ECE-A1FB-EACB032C8A38Q34019957-D3591FEB-A6FF-444E-B587-A4B40C9E71C5Q34024731-03B7D92D-3A08-4B23-ACDB-D22CE3232BD3Q34431468-4CC8892F-A931-4452-AA78-8B4AFE016FF1Q34502015-F7603E8E-DF12-4508-BC99-FBB033ACBDC8Q34632766-096EF2E0-489F-4510-AF39-D80CD1E341C6Q35067867-9BD3DAF6-774C-45E2-8B57-3F04C0F46425Q35098085-581DCCCE-7998-4054-8BC3-B3B81F583712Q35232419-AA8C1D21-E867-4DBA-A0E3-FE37FCDDC4BBQ35633988-5CA777F3-7ACD-4CC2-BACA-78D3FE63786CQ35919814-2F9083CC-84F8-44BC-8B88-C3D2F389BB59Q35971814-10B732FC-2269-4939-AD92-B06480925A1CQ35988303-4349F37A-25C4-4BDE-949A-7642C1CB84BBQ36065252-579335A2-1BAF-435D-93EE-160D772C29C8Q36094140-EBFD9B2E-7A0D-4132-9775-A2FE2C29C14BQ36536055-52A144D6-D5FA-4DBC-B390-D666EDDCBAA6Q36591911-87175061-4557-4591-887C-345E54DDA37AQ36671901-7694BF03-2EEE-4F6C-B93B-E9270EDBA0CBQ36877844-DCBAAD1A-654A-4FB1-AE8B-48DAA13A6149Q37001123-E1D9AEE6-8EF1-46A0-9B8F-205AD9A9BB0EQ37186606-4684CE8B-5E2C-436D-925F-219D3306B5A6Q37224641-6DCD0E59-BFFE-4FB5-80B0-B6FFB216DD52Q37233401-4FD6EC9C-867A-4713-9F42-61FA81353626Q37684607-E098E47A-F3EF-43F8-8A1D-733176CE09C7Q37696020-F2D52F07-B131-45C6-8DFD-7DDA63C8ECF4Q37706070-35B6F61E-EF1C-41C2-8AE1-EBD259DB46E9Q37729931-D5BEBF6A-71BF-45A1-A955-3D9C2BEB1837Q37730044-504767EB-7C72-4E0A-855E-6EF632A520E6Q37973017-51BB8410-5984-4E3E-857F-782719EF431CQ38007998-F48CDE36-DB6B-48B0-BB8C-3A3CF2C2DEF1Q38040369-E616E079-B5C6-4546-AC79-9252701DDAFBQ38254499-CE9FB10D-6ADF-4B4A-BD75-AAF3D4803858
P2860
The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@ast
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@en
type
label
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@ast
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@en
prefLabel
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@ast
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@en
P2093
P2860
P356
P1476
The E-cadherin repressor Snail ...... al of ovarian cancer patients.
@en
P2093
B Schmalfeldt
K Blechschmidt
K-F Becker
T Schuster
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604115
P407
P577
2007-11-20T00:00:00Z